Top U.S. SNRIs based on revenue 2013

This statistic displays the top nine serotonin-norepinephrine reuptake inhibitors (SNRIs) based on total U.S. revenue in 2013. In that year, Pristiq was among the leading SNRIs generating 570 million U.S. dollars in revenue in the United States. SNRIs are a type of antidepressant drug used to treat major depression disorder or other mood disorders. They can also be used for anxiety disorders, obsessive-compulsive disorder, and other related disorders.

本统计数据显示了基于2013年美国总营收排名前九位的5-羟色胺-去甲肾上腺素再摄取抑制剂（SNRIs）。当年，普立司琼作为领先的SNRIs之一，在美国市场创造了5.7亿美元的营收。SNRIs是一种抗抑郁药物，主要用于治疗重度抑郁症或其他情感障碍。此外，它们也可用于焦虑症、强迫症及其他相关病症的治疗。